The VERITON-CT 400 Series is based on the Spectrum Dynamics digital SPECT/CT platform and offers higher sensitivity and throughput for Nuclear Medicine clinical applications
Spectrum Dynamics Medical and radiation detection solutions maker Kromek Group have unveiled a new digital SPECT/CT scanner, VERITON-CT 400 series.
According to Spectrum Dynamics, the VERITON-CT 400 series is a result of the integration of Kromek CZT detectors in Spectrum digital SPECT/CT.
The scanner uses up to 400keV high-energy isotopes to offer higher sensitivity and throughput for nuclear medicine clinical applications.
CZT detectors are said to reduce scan times, lower radiation dose to the patient, and improve image quality and quantitative accuracy.
Spectrum Dynamics CEO Gilad Yoeli said: “Clinical users across the world provide us with feedback on the Nuclear Medicine challenges they face.
“Providing the technology to address such challenges is what drives us. The increased sensitivity, improved energy resolution, and broader energy range of Kromek’s detector technology make it the right choice for the 400 Series and the advanced imaging and quantitative accuracy clinical users ask for.”
Kromek’s digital detectors combine Spectrum’s 360-degree, wide-bore SPECT/CT scanner and its advanced image reconstruction algorithms to meet the throughput demands of present and forthcoming nuclear medicine applications.
Spectrum claimed that the energy range, system sensitivity, and energy resolution have all been improved by 2-4 times in the 400 Series digital detector technology, which sets new benchmarks.
The firm noted that these developments would reduce the scan times associated with modern analogue or digital technologies.
Kromek Group CEO Arnab Basu said: “We are delighted that our CZT detectors have been integrated into Spectrum Dynamics’ VERITON-CT 400 SPECT/CT systems.
“This enables enhanced image quality and breakthrough clinical capabilities in digital SPECT/CT.
“Spectrum Dynamics has long been at the forefront of developing next-generation SPECT/CT scanners to deliver better patient outcomes and we are pleased to be part of this significant advance in nuclear medical imaging technology.”